Accessibility Menu
Microbix Biosystems logo

Microbix Biosystems

(TSX) MBX

Current PriceCA$0.27
Market CapCA$37.41M
Since IPO (1992)-55%
5 Year-54%
1 Year-17%
1 Month+8%

Microbix Biosystems Financials at a Glance

Market Cap

CA$37.41M

Revenue (TTM)

CA$14.81M

Net Income (TTM)

-CA$5.72M

EPS (TTM)

-CA$0.04

P/E Ratio

-6.59

Dividend

CA$0.00

Beta (Volatility)

0.33 (Low)

Price

CA$0.27

Volume

33,258

Open

CA$0.28

Previous Close

CA$0.27

Daily Range

CA$0.27 - CA$0.28

52-Week Range

CA$0.21 - CA$0.34

MBX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Microbix Biosystems

Industry

Biotechnology

CEO

Cameron L. Groome

Headquarters

Mississauga, ON L4Z 1P3, CA

MBX Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

-33%

Net Income Margin

-39%

Return on Equity

-20%

Return on Capital

-16%

Return on Assets

-16%

Earnings Yield

-15.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$37.41M

Shares Outstanding

138.55M

Volume

33.26K

Avg. Volume

57.98K

Financials (TTM)

Gross Profit

CA$9.85M

Operating Income

-CA$1.58M

EBITDA

CA$428.23K

Operating Cash Flow

-CA$80.29K

Capital Expenditure

-CA$797.29K

Free Cash Flow

-CA$877.58K

Cash & ST Invst.

CA$12.11M

Total Debt

CA$6.77M

Microbix Biosystems Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$3.38M

-36.6%

Gross Profit

CA$1.63M

-48.6%

Gross Margin

48.20%

N/A

Market Cap

CA$37.41M

N/A

Market Cap/Employee

CA$374.09K

N/A

Employees

100

N/A

Net Income

-CA$1.43M

-7021.9%

EBITDA

-CA$798.84K

-214.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

CA$1.33M

-85.5%

Accounts Receivable

CA$3.26M

+29.8%

Inventory

CA$10.08M

+21.8%

Long Term Debt

CA$5.85M

+11.5%

Short Term Debt

CA$941.46K

+861.9%

Return on Assets

-16.18%

N/A

Return on Invested Capital

-15.80%

N/A

Free Cash Flow

-CA$530.40K

-173.5%

Operating Cash Flow

-CA$307.77K

-131.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LABS.TOMediPharm Labs Corp.
CA$0.08+0.00%
RVX.TOResverlogix Corp.
CA$0.10-5.00%
ROMJ.VRubicon Organics Inc.
CA$0.42-1.18%
ADK.VDIAGNOS Inc.
CA$0.23+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCEVirgin Galactic
$6.18+0.36%
SOFISoFi Technologies
$18.22+0.07%
ONDSOndas
$13.22-0.00%
NOKNokia
$14.84-0.03%

Questions About MBX

What is the current price of Microbix Biosystems?

Microbix Biosystems is trading at CA$0.27 per share.

What is the 52-week range for Microbix Biosystems?

Over the past 52 weeks, Microbix Biosystems has traded between CA$0.21 and CA$0.34.

How much debt does Microbix Biosystems have?

As of the most recent reporting period, Microbix Biosystems reported total debt of CA$6.80M.

How much cash does Microbix Biosystems have on hand?

Microbix Biosystems reported CA$8.13M in cash and cash equivalents in its most recent financial results.

What is Microbix Biosystems’s dividend yield?

Microbix Biosystems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.